Barriers and Facilitators to Screening for Kidney Disease Among Older Adults with Hypertension and Diabetes in Mbarara Southwestern Uganda: Healthcare Providers' Perspective
Judith Owokuhaisa,Catherine Abaasa,Rose Muhindo,Pius Musinguzi,Godfrey Rukundo
DOI: https://doi.org/10.2147/jmdh.s451533
2024-02-29
Journal of Multidisciplinary Healthcare
Abstract:Judith Owokuhaisa, 1 Catherine N Abaasa, 2 Rose Muhindo, 3 Pius Musinguzi, 4 Godfrey Zari Rukundo 5 1 Faculty of Medicine, Department of Physiotherapy, Mbarara University of Science and Technology, Mbarara, Uganda; 2 Faculty of Medicine, Department of Medical Laboratory Sciences, Mbarara University of Science and Technology, Mbarara, Uganda; 3 Faculty of Medicine, Department of Internal Medicine, Mbarara University of Science and Technology, Mbarara, Uganda; 4 Faculty of Medicine, Department of Nursing, Mbarara University of Science and Technology, Mbarara, Uganda; 5 Faculty of Medicine, Department of Psychiatry, Mbarara University of Science and Technology, Mbarara, Uganda Correspondence: Judith Owokuhaisa, Email Background: Screening for kidney disease (KD) among high-risk patients (patients with hypertension or diabetes) allows early diagnosis, intervention and delayed progression of the disease. In low- and middle-income countries (LMIC), KD screening is still sub-optimal. This study explored the healthcare providers' perceived barriers and facilitators to KD screening among older adults with hypertension and diabetes in Mbarara southwestern Uganda. Methods: This was a descriptive qualitative study among healthcare providers caring for older adults with diabetes mellitus and hypertension at Mbarara Regional Referral Hospital (MRRH) in southwestern Uganda. In-depth interviews were conducted using a semi-structured interview guide. Interviews were audio-recorded, transcribed verbatim, and thematically analyzed to develop themes of barriers and facilitators. Results: We conducted 30 in-depth interviews among healthcare providers. Barriers to screening for kidney disease included patient related factors according to healthcare providers (financial hardships, poor health seeking behavior, limited knowledge and awareness), healthcare factors (work overload, ineffective patient healthcare provider communication) and system/policy related factors (lack of laboratory supplies, lack of guidelines and poor medical record keeping and documentation). With respect to facilitators, we found formation of peer support groups, effective team, and continuous medical education (CME). Conclusion: Healthcare providers encounter substantial but modifiable barriers in screening older adults for KD. The identification of barriers and facilitators in timely KD detection gives us an outlook of the problem in Uganda and leads for proposals of action. Interventions that address these barriers and promote facilitators may improve the healthcare provider's effectiveness and capacity to care including screening for patients at risk of KD. Keywords: healthcare providers, barriers, facilitators, screening, kidney disease, hypertension, diabetes, older, adults Kidney disease is the 10 th leading cause of death globally and projections show that chronic kidney disease (KD) will become the 5 th leading cause of death by the year 2040. 1 KD is increasing in incidence and prevalence worldwide and is estimated to be between 13.4% and 14.3% accounting for approximately 1.2 million deaths per year. 2 Co-morbidity of diabetes mellitus and hypertension dramatically increases the risk of developing kidney disease. KD has now emerged as a significant public health challenge in sub‐Saharan Africa with a reported prevalence of 13.9%. 3 The prevalence of KD in Mbarara has been shown to be 15.3% in a study done at MRRH. 4 As a non-communicable disease, KD has not received the necessary attention in most countries in sub‐Saharan Africa including Uganda. 5 KD is associated with increasing morbidity and mortality and also known to impact negatively on quality of life. 6 The magnitude of mortality among this age group is about 59% (Anecdotal records of renal unit MRRH, 2022). Progression of KD to end‐stage kidney disease (ESKD) is an important burden to the healthcare system in most low middle income countries (LMICs) as most patients cannot afford renal replacement therapy. Prevention, early detection, and intervention may prevent onset of KD and reduce the likelihood of KD progression to end-stage renal disease (ESRD). 7 ESRD requires advanced and expensive renal replacement therapies like dialysis or kidney transplant for treatment. These treatment modalities are not readily available in developing countries or even where they are available, their cost pose an immense financial burden on patients and their families. 8 In 2010, global estimates showed that over half of people requiring renal replacement therapies died due to lack of access to dialysis or kidney transplant -Abstract Truncated-
health care sciences & services